- Home
- TRS vs FBIO Comparison
TRS vs FBIO Comparison
Compare TRS & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- FBIO
- Stock Information
- Founded
- TRS 1986
- FBIO 2006
- Country
- TRS United States
- FBIO United States
- Employees
- TRS N/A
- FBIO N/A
- Industry
- TRS Industrial Specialties
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- TRS Industrials
- FBIO Health Care
- Exchange
- TRS Nasdaq
- FBIO Nasdaq
- Market Cap
- TRS N/A
- FBIO 49.1M
- IPO Year
- TRS 2007
- FBIO N/A
- Fundamental
- Price
- TRS $24.52
- FBIO $1.69
- Analyst Decision
- TRS Strong Buy
- FBIO Strong Buy
- Analyst Count
- TRS 1
- FBIO 3
- Target Price
- TRS $40.00
- FBIO $21.00
- AVG Volume (30 Days)
- TRS 496.1K
- FBIO 146.2K
- Earning Date
- TRS 04-29-2025
- FBIO 05-19-2025
- Dividend Yield
- TRS 0.65%
- FBIO N/A
- EPS Growth
- TRS N/A
- FBIO N/A
- EPS
- TRS 0.77
- FBIO N/A
- Revenue
- TRS $939,580,000.00
- FBIO $57,675,000.00
- Revenue This Year
- TRS $6.34
- FBIO $63.20
- Revenue Next Year
- TRS $3.39
- FBIO $66.70
- P/E Ratio
- TRS $31.70
- FBIO N/A
- Revenue Growth
- TRS 3.80
- FBIO N/A
- 52 Week Low
- TRS $19.33
- FBIO $1.33
- 52 Week High
- TRS $28.51
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- TRS 64.30
- FBIO 52.97
- Support Level
- TRS $20.59
- FBIO $1.67
- Resistance Level
- TRS $25.13
- FBIO $1.84
- Average True Range (ATR)
- TRS 1.10
- FBIO 0.09
- MACD
- TRS 0.40
- FBIO 0.01
- Stochastic Oscillator
- TRS 80.78
- FBIO 58.54
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.